Síntese e caracterização de potenciais metalofármacos contendo ligantes azólicos contra Doença de Chagas
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Chagas disease is an illness that plagues the most vulnerable populations in emerging
tropical countries, with millions of prevalent cases reported across the planet. Data indicate that
if the disease is not treated properly, the chances of death are high, due to the imminent risk of
heart attacks. Currently, the only chemotherapy option available is the drug Benznidazole
(BZN), whose biological activity against Trypanosoma cruzi, the parasite that caused the
disease, is limited or even ineffective in some cases. Furthermore, studies have shown that
Fexinidazole (FXZ), a medication administered to treat sleeping sickness caused by the
protozoan Trypanosoma brucei, has a good response against the parasite that transmits Chagas
disease in in vivo trials. Due to the lack of a completely effective therapy for the disease, this
work presents an alternative proposal based on enhancing the biological activity of a drug by
coordinating it with a transition metal. In this way, 10 new metal complexes derived from
Benznidazole and Fexinidazole were synthesized with the metal ions of Pt(II), Pd(II), Zn(II),
Au(I) and Au(III), which were characterized by Nuclear Magnetics Resonance, Elemental
Analysis, Conductimetry, Vibrational Spectroscopy in the Infrared and Raman region, UV-Vis
Electronic Spectroscopy and X-ray Diffraction (for one of the structures), with the purpose of
evaluating their potential biological activities against the parasite that transmits the disease of
Chagas. Furthermore, computational studies were directed to investigate the possible
interactions of some metal complexes synthesized with DNA using the Molecular Docking
method.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

